Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8374
Peer-review started: July 29, 2021
First decision: October 16, 2021
Revised: October 25, 2021
Accepted: December 16, 2021
Article in press: December 16, 2021
Published online: December 28, 2021
Processing time: 147 Days and 9.9 Hours
In a recent systematic review and meta-analysis of observational studies, the author found potential errors in the selection and extraction processes. The recalculated summary relative risks and the results of a dose-response meta-analysis showed that oral contraceptive use may not be associated with the risk of pancreatic cancer in women.
Core Tip: A systematic review and meta-analysis of observational studies conducted recently concluded that oral contraceptive use was associated with a decreased risk of pancreatic cancer in women. However, the author found potential errors in the selection and extraction processes. The recalculated summary relative risks and the results of a dose-response meta-analysis showed that oral contraceptive use may not be associated with the risk of pancreatic cancer in women. As this conclusion contradicted that reported recently, it is necessary to re-evaluate the direction and statistical significance of this risk through an updated meta-analysis in the future.